CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-21 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −593 | $42.55 | $25K | 176,192 |
| 2022-02-21 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Deferred Stock Units | −1,714 | 1,714 | ||
| 2022-02-21 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +623 | 30,922 | ||
| 2022-02-21 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −180 | $42.55 | $8K | 30,742 |
| 2022-02-21 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Deferred Stock Units | −623 | 623 | ||
| 2022-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +2,804 | 141,632 | ||
| 2022-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −859 | $42.55 | $37K | 140,773 |
| 2022-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Deferred Stock Units | −2,804 | 2,804 | ||
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,013 | 34,249 | ||
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −298 | $42.55 | $13K | 33,951 |
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,013 | 1,013 | ||
| 2022-02-21 | Mahoney Michael F Chairman, President & CEO | Exercise or conversion | +16,825 | 2,130,384 | ||
| 2022-02-21 | Mahoney Michael F Chairman, President & CEO | Shares withheld for taxes | −7,462 | $42.55 | $318K | 2,122,922 |
| 2022-02-21 | Mahoney Michael F Chairman, President & CEO | Exercise or conversion · Deferred Stock Units | −16,825 | 16,825 | ||
| 2022-02-21 | Mackey Edward F EVP, Operations | Exercise or conversion | +2,726 | 52,793 | ||
| 2022-02-21 | Mackey Edward F EVP, Operations | Shares withheld for taxes | −1,209 | $42.55 | $51K | 51,584 |
| 2022-02-21 | Mackey Edward F EVP, Operations | Exercise or conversion · Deferred Stock Units | −2,726 | 2,726 | ||
| 2022-02-21 | Fitzgerald Joseph Michael EVP & Pres, Cardiology | Exercise or conversion | +3,895 | 217,970 | ||
| 2022-02-21 | Fitzgerald Joseph Michael EVP & Pres, Cardiology | Shares withheld for taxes | −1,923 | $42.55 | $82K | 216,047 |
| 2022-02-21 | Fitzgerald Joseph Michael EVP & Pres, Cardiology | Exercise or conversion · Deferred Stock Units | −3,895 | 3,895 |
Page 73 of 87 · 1,736 trades